Multicenter Clinical Evaluation of ETEST Eravacycline for Susceptibility Testing of Enterobacteriaceae and Enterococci

Eravacycline (ERV) (brand name Xerava [Tetraphase]) is a new tetracycline-class antibacterial that has been approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for treatment of complicated intra-abdominal infections (cIAIs). ETEST is a gradient diffusion m...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanchard, Laurine S., Armstrong, Thomas P., Kresken, Michael, Emery, Christopher L., Ying, Yun X., Sauvonnet, Véronique, Zambardi, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Bacteriology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035295/
https://www.ncbi.nlm.nih.gov/pubmed/36877080
http://dx.doi.org/10.1128/jcm.01650-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035295/
https://www.ncbi.nlm.nih.gov/pubmed/36877080
http://dx.doi.org/10.1128/jcm.01650-22

Ejemplares similares